Pembrolizumab (pembro) vs paclitaxel (PTX) for previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer: Phase 3 KEYNOTE-061 trial.


Fuchs C. S., Ozguroglu M., Bang Y., Di Bartolomeo M., Mandala M., Ryu M., ...Daha Fazla

JOURNAL OF CLINICAL ONCOLOGY, cilt.36, sa.15, 2018 (SCI-Expanded) identifier